24 April 2018 : Clinical Research
Platelet Distribution Width in Hepatocellular Carcinoma
Fenfen Guo1ABCEF, Xuan Zhu1B, Xue Qin1EG*DOI: 10.12659/MSM.909474
Med Sci Monit 2018; 24: CLR2518-2523
Abstract
BACKGROUND: Platelets and platelet activation are involved in the critical steps of tumor cell growth, metastasis, and angiogenesis. In this study, we analyzed the correlation between platelet distribution width (PDW) and hepatocellular carcinoma (HCC).
MATERIAL AND METHODS: HCC patients at the First Affiliated Hospital of Guangxi Medical University, China, from January 2017 to October 2017, were analyzed retrospectively. The control group comprised healthy persons at the hospital for medical check-ups during the same period. The Mann-Whitney U test was performed to compare the differences in relevant laboratory parameters between the HCC and control groups. Differences in PDW at different stages of HCC were calculated by using one-way analysis of variance. The Spearman correlation analysis was used to analyze the correlations between the PDW and relevant experimental parameters in HCC patients.
RESULTS: The platelet distribution width (PDW), mean platelet volume (MPV), and neutrophil-to-lymphocyte ratio (NLR) were higher in HCC patients than in the control group. The platelet count (P), absolute lymphocyte count (L), absolute neutrophil count (N), and platelet-to-lymphocyte ratio (PLR) were distinctly lower in the HCC patients than in the control group. There were significant differences in the PDW between the 4 stages of HCC. The Spearman correlation analysis demonstrated that the PDW was positively correlated with the cancer stage, alpha fetoprotein (AFP), and MPV, and negatively correlated with the platelet-to-lymphocyte ratio (PLR) and platelet count (P). The area under the receiver-operating characteristic curve of the platelet distribution width-to-platelet count ratio was 0.727 (95% confidence interval 0.691–0.762).
CONCLUSIONS: PDW is associated with HCC and may be a potential marker for its progression.
Keywords: Platelet Activation, Systemic Inflammatory Response Syndrome
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952